top of page

CannaLife Presents, A MISFIT Manifesto: The Missing Middle

  • Writer: Jessica Humphreys
    Jessica Humphreys
  • 4 hours ago
  • 5 min read

Consumer-First Plant Medicine Communication for the Space Between Hype, Fear and Real Life

The MISFIT Manifesto by CannaLife Press featuring evidence-based articles on cannabis science, toxicology, psychedelics, pharmacology, integrated health, consumer safety and scientific literacy.


The Missing Middle: A MISFIT Manifesto for Consumer-First Plant Medicine Communication


Let’s stop pretending the cannabis and psychedelic medicine conversations fit into some neat little wellness box happening in clean rooms with perfect lighting and tidy language. My question is, why do they need to?


Real people are messy. And real people are already using these products medicinally, recreationally and everywhere in between. And honestly, we need to stop acting like the social and recreational cannabis consumption are automatically separate from medicine.


They are not. And the egomaniacs that promote this separate and divided existence do not amuse me.


Recreational Cannabis

Connection is medicine.

Joy is medicine.

Laughter is medicine.

Relief is medicine.

Getting out of your own head and way can be medicine.


Sitting with other humans, sharing a joint, talking honestly, remembering you are not alone and feeling your nervous system loosen its grip can matter, medicinally.


This does not mean every recreational use is therapeutic.


It does mean we should be careful about pretending “medicine” only counts when it looks clinical, sterile, prescribed, documented and supervised.


Humans are social animals.

Isolation harms health.

Connection supports health.


So when cannabis helps people gather, talk, laugh, eat, rest, grieve, process or feel human again, I am not interested in dismissing that just because it happened outside a clinic.


Medical Cannabis

Medical cannabis is where the same lie gets dressed up differently.

Recreational use gets dismissed because it looks too social, too joyful or too culturally inconvenient.


Medical use gets sanitized until it no longer looks like the real people who need it.

But medical cannabis is not always a polished wellness story.


It often enters the conversation when someone is already sick, wasting, nauseated, terrified, overmedicated, under-treated, under-believed or simply trying to experience less suffering.


People with cancer who are wasting away from the disease, the treatment or both.

People with AIDS, autoimmune disease, chronic pain, menopause symptoms, appetite loss, nausea, insomnia, anxiety, trauma and nervous systems that never got the memo about “just relax.”


People who overdosed yesterday and still woke up needing relief from the same pain they were trying to outrun.

People who have stuck needles in their own bodies to get high, to get numb, to get through the night, to not feel the thing nobody wanted to sit down and ask about.

People who are mixing cannabis with prescriptions, alcohol, nicotine, caffeine, supplements, herbs, psychedelics and whatever else they are using to survive their actual lives.


People whose doctors do not know enough.

People whose families are embarrassed by them.

People whose stories make polite society uncomfortable.

People my own mother would have wanted me to avoid on the sidewalk.


And that is exactly where I have always been different.


I am not afraid to sit down with the addict.

I am not afraid to ask the question or get the answer.

I am not afraid of the homeless man, the cancer patient, the traumatized woman, the neurodivergent kid or the new smiling face who passes me a blunt outside my hotel in Delaware.


That is the work.


Not pretending people are more perfect than they are.

Not pretending health decisions happen in ideal conditions.

Not pretending clinicians, brands, regulators or wellness influencers understand the whole picture from a distance.


The Reality Is This

People are already experimenting.


Neurodivergent people have been self-observing and self-medicating since the beginning of time.

Trauma survivors are already looking for relief in some very right and some very wrong places.


Cancer patients, chronic pain patients, former smokers, current smokers, caregivers, veterans, burnt-out mothers, anxious professionals, grieving people and people who have been failed by every system around them are already figuring out what helps, whether “polite” society has left them behind or not.


And too many professionals are still scared to talk about it like it’s real.

Too many brands are too busy selling.

Too many clinicians are too cautious, too constrained or too disconnected from cannabis culture to be fully trusted by the people who have lived inside it for decades. State licensing boards are no joke, trust me, I know.


Too many families still think the embarrassing part is talking to “those people,” instead of asking why “those people” were left outside the conversation in the first place.


Well, FUCK THAT.


CannaLife belongs in the missing middle.

The place between hype and fear.


Between clinical caution and lived experience.

Between cannabis culture and medical authority.

Between the person using the product and the professional who may want to help but doesn't know how to have the conversation.


Because some people do not need another lecture.


They need someone willing to sit down, cut the shit, ask the real question, hear the messy truth and help turn it all into something useful.


Further Reading & References

National Academies of Sciences, Engineering and Medicine — The Health Effects of Cannabis and Cannabinoids A major evidence review on cannabis and cannabinoids, including therapeutic effects, risks, uncertainties and research gaps. This is a useful grounding source for cannabis education that does not collapse into hype or fear. (NCBI Bookshelf)


Macedo et al. — “Online Information on Medical Cannabis May Raise Unrealistic Expectations and Downplay Potential Side Effects” This research article analyzed online medical cannabis information and found that public-facing content can raise unrealistic expectations while leaving out important safety context. The authors reported that only 22% of reviewed webpages mentioned potential side effects. (arXiv)


Holt-Lunstad, Smith and Layton — “Social Relationships and Mortality Risk: A Meta-analytic Review” A widely cited PLOS Medicine meta-analysis on social relationships and mortality risk. This supports the broader point that connection, isolation and social belonging are not fluffy wellness extras; they are health-relevant. (PLOS Medicine)


National Academies of Sciences, Engineering and Medicine — Social Isolation and Loneliness in Older Adults: Opportunities for the Health Care System A major report on loneliness, social isolation and health. Useful support for the idea that connection and social context belong in serious health conversations, not just lifestyle fluff. (National Academies)


Rønne et al. — “Communication Between Healthcare Providers and Medical Cannabis Patients Regarding Referral and Medication Substitution” A Journal of Cannabis Research article on medical cannabis patient-provider communication, including why patients may avoid discussing cannabis use with providers because of stigma or legal concerns. (Journal of Cannabis Research / Springer Nature)


Ng et al. — “Healthcare Provider and Medical Cannabis Patient Communication Regarding Referral and Medication Substitution: The Canadian Context” Another Journal of Cannabis Research article exploring patient-provider communication around medical cannabis, including concerns about healthcare provider knowledge, stigma and legal or professional ramifications. (Journal of Cannabis Research / Springer Nature)


Vandrey et al. — “Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products” A JAMA study showing variability in cannabis edible label accuracy. Useful support for the point that product literacy, testing, labeling and consumer education matter. (JAMA)


Spindle et al. — “Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores” A JAMA Network Open study on cannabinoid content and label accuracy in hemp-derived topical products. Helpful for grounding concerns about product claims, labeling and consumer trust. (JAMA Network Open)


Journal of Cannabis Research — cannabis patient-provider communication and substitution research For readers interested in the broader research ecosystem, Journal of Cannabis Research has multiple open-access studies examining medical cannabis use, communication, patient behavior, substitution and stigma. (Journal of Cannabis Research)


Welcome to the MISFITS.

I don't expect you'll agree with everything you read here.

But I do expect you'll at least think about it.


That's enough.


If this article made you think...


Share it.

Quote it.

Debate it.

Teach it.

Email it.

Text it to someone who needs to read it.

If you found value here, help someone else find it too.


Please keep my name attached and link back to the original article whenever you share it.


Because good ideas don't belong in echo chambers.


They belong in conversations.


Jessica Humphreys, BSN

Founder | CannaLife® | CannaLife MISFITS™ | MC Jazzi O™ | CannaLife Press™ | CannaRx™




Comments


bottom of page